The U.S. Court of Appeal for the D.C. Circuit has temporarily delayed the November 1st Direct Observation (DO) requirement for DOT return-to-duty and follow-up tests. This is an “administrative stay” until the Court completes its review on the matter. Therefore, DO for return-to-duty and follow-up testing will continue to be an employer option, rather than mandatory. We will let you know when the Court makes a decision on the matter.

If you are using the Company Policy Templates (AntiDrug) provided by NATA Compliance Services, please ensure you continue to use version 2008.08.

If you have any questions or need assistance, please contact our Customer Service Department 1-800-788-3210